510(k) Report

510(k) · Cleared

Cleared

Triage BNP Test, Model 98000XR

K051787510(k) TraditionalCleared Sep 22, 200583-day reviewClass II21 CFR 862.1117

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Biosite Incorporated · NBC Test, Natriuretic Peptide

Cleared on Sep 22, 2005 as substantially equivalent to K021317 (Biosite Incorporated, 2002) and 1 other predicate after an 83-day review. Its family tree reaches back 3 generations to 2000. 1 of the 11 devices in its family, counting itself, has a Class I recall. 6 later devices descend from it.

Decided
Sep 22, 2005
Review
83 days
Class
Class II
Product code
NBC
Recalls
None
Predicates
2

Its longest line of descent runs back 3 generations to DEN000010 (2000). 4 ancestors in all. 6 later devices descend from it, 3 citing it directly. 1 of the 11 devices in this family, counting this one, has a Class I recall.

Other ancestors, by year clearedDescendants, by year cleared 2002: 1 other ancestor2008: 1 descendant cleared, 1 with a Class I recall12010: 1 descendant cleared2006: 1 descendant cleared2026: 1 descendant cleared2014: 1 descendant cleared2011: 1 descendant clearedDEN000010 · Triage B-Type Natriuretic Peptide (BNP) Test · Biosite Incorporated · 2000K022516 · Elecsys Probnp Immunoassay · Roche Diagnostics Corp. · 2002K032646 · Elecsys Probnp Immunoassay · Roche Diagnostics Corp. · 2003200020052010201520202025
Other ancestors, by generationDescendants, by generation 1 generation back: 1 other ancestor 1 generation forward: 3 descendants, 1 with a Class I recall12 generations forward: 3 descendants K032646 · Elecsys Probnp Immunoassay · Roche Diagnostics Corp. · 2003K022516 · Elecsys Probnp Immunoassay · Roche Diagnostics Corp. · 2002DEN000010 · Triage B-Type Natriuretic Peptide (BNP) Test · Biosite Incorporated · 20000
  1. Root · 3 generations backDEN000010 Triage B-Type Natriuretic Peptide (BNP) TestBiosite Incorporated · 2000
  2. 2 generations backK022516 Elecsys Probnp ImmunoassayRoche Diagnostics Corp. · 2002
  3. 1 generation backK032646 Elecsys Probnp ImmunoassayRoche Diagnostics Corp. · 2003
  4. This deviceK051787 Triage BNP Test, Model 98000XRBiosite Incorporated · 2005
  5. Descendant · cites it directly · 4 of its ownK052789 Triage BNP Test for Beckman Coulter Immunoassay Systems, Model 98200Biosite Incorporated · 2006 · Recalled
  6. Descendant · cites it directly · 3 of its ownK080269 Triage Cardioprofiler and Profiler S.O.B. PanelsBiosite Incorporated · 2008 · Recalled (Class I)
  7. Descendant · cites it directly · 2 of its ownK093758 BGM Galectin -3Bg Medicine, Inc. · 2010
  8. Descendant · 2 generations on · 0 of its ownK252169 Access BNP IIBeckman Coulter, Inc. · 2026
  9. Descendant · 2 generations on · 0 of its ownK140436 ARCHITECT GALECTIN-3 Reagent Kit, ARCHITECT GALECTIN-3 CALIBRATORS…Fujirebio Diagnostics,Inc. · 2014

Showing 5 of 6 descendants. See all descendants

Descendants cleared per year

2006: 12008: 12010: 12011: 12014: 12026: 1
2006high 1 (2006) · low 0 (2007)2026

Class I recalls in this family

Most influential descendants

Showing 5 of 6 · See all
  • K052789Triage BNP Test for Beckman Coulter Immunoassay Systems, Model 98200Biosite Incorporated · 2006 · cites it directly4descendants
  • K080269Triage Cardioprofiler and Profiler S.O.B. PanelsBiosite Incorporated · 2008 · cites it directly3descendants
  • K093758BGM Galectin -3Bg Medicine, Inc. · 2010 · cites it directly2descendants
  • K252169Access BNP IIBeckman Coulter, Inc. · 2026 · 2 generations on0descendants
  • K140436ARCHITECT GALECTIN-3 Reagent Kit, ARCHITECT GALECTIN-3 CALIBRATORS, ARCHITECT GALECTIN-3…Fujirebio Diagnostics,Inc. · 2014 · 2 generations on0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−3DEN000010Triage B-Type Natriuretic Peptide (BNP) TestBiosite Incorporated2000—
−2K022516Elecsys Probnp ImmunoassayRoche Diagnostics Corp.2002—
−1K032646Elecsys Probnp ImmunoassayRoche Diagnostics Corp.2003—
0 (this device)K051787Triage BNP Test, Model 98000XRBiosite Incorporated2005—
+1K052789Triage BNP Test for Beckman Coulter Immunoassay Systems, Model 98200Biosite Incorporated20061
+1K080269Triage Cardioprofiler and Profiler S.O.B. PanelsBiosite Incorporated2008Class I
+1K093758BGM Galectin -3Bg Medicine, Inc.2010—
+2K252169Access BNP IIBeckman Coulter, Inc.2026—
+2K140436ARCHITECT GALECTIN-3 Reagent Kit, ARCHITECT GALECTIN-3 CALIBRATORS, ARCHITECT…Fujirebio Diagnostics,Inc.2014—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
200210

Descendants by year cleared

Year clearedDevicesWith a Class I recall
200610
200811
201010
201110
201410
202610
FIG. 1 — Lineage of K051787, 2000–2026Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

1 device in this family has a Class I recall. A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new NBC device

  1. #1 K262109 Access NT-proBNPscore 13.8 · 7 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (2)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K021317Triage B-Type Natriuretic Peptide (BNP) Test
Summary page 1
…R. Dahlen, Ph.D. Date Summary Prepared: September 17, 2005 B. Product Triage® BNP Test C. Predicate Devices Biosite Triage BNP Test (K021317) Roche Elecsys ProBNP Immunoassay (K032646) D. Device Description and Intended Use The Triage BNP Test is a rapid,…
Biosite Incorporated2002—
*K032646Elecsys Probnp Immunoassay
Summary page 1
…September 17, 2005 B. Product Triage® BNP Test C. Predicate Devices Biosite Triage BNP Test (K021317) Roche Elecsys ProBNP Immunoassay (K032646) D. Device Description and Intended Use The Triage BNP Test is a rapid, point of care fluorescence immunoassay to…
Roche Diagnostics Corp.2003—

Also cleared against K021317: 5 other devices →

What descends from it? (6)

3 later devices cite it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K052789Triage BNP Test for Beckman Coulter Immunoassay Systems, Model 98200Biosite Incorporated20064
K080269Triage Cardioprofiler and Profiler S.O.B. Panels Class IBiosite Incorporated20083
K093758BGM Galectin -3Bg Medicine, Inc.20102

Has anything in its family been recalled? (1 Class I)

No FDA recall names this device.

Relatives with a Class I recall

Class I is FDA’s most serious recall class. A recall in the family tree is context for this device, not evidence about it.

  • K080269Triage Cardioprofiler and Profiler S.O.B. PanelsBiosite Incorporated · 2008 · Cites it directly · ◆ in the 2008 descendants bar of FIG. 12 Class I recalls

What does this lineage say?

  • The line of descent spans 5 years and passes through 2 companies; a new generation was cleared every 1.9 years on median.
  • None of the 4 ancestors has a recall.
  • Of its descendants, K052789 (Biosite Incorporated, 2006) has gone furthest, with 4 descendants of its own.
  • 5 other devices also cite its predicate K021317.

How does its category compare?

All NBC devices

NBC Test, Natriuretic Peptide: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · NBC

1in 2025

2007: 22008: 72010: 12020: 12021: 22022: 12023: 22024: 12025: 12026 (partial year): 4
2007high 7 (2008) · low 0 (2009)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · NBC

126in 2008

2008: 126 days median2026 (partial year): 94 days median
2007high 126 (2008)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · NBC

1in 2020

2010: 12012: 22014: 12015: 12018: 12020: 1
2007high 2 (2012) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · NBC

17in 2025

2007: 172008: 152009: 352010: 612011: 532012: 232013: 132014: 702015: 432016: 312017: 92018: 72019: 92020: 62022: 42023: 262024: 142025: 17
2007high 70 (2014) · low 0 (2021)2025

MAUDE reports naming product code NBC, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20072—017
20087126015
20090—035
20101—161
20110—053
20120—223
20130—013
20140—170
20150—143
20160—031
20170—09
20180—17
20190—09
20201—16
20212—00
20221—04
20232—026
20241—014
20251—017
20264940—

What is it indicated for?

The Triage® BNP Test is a rapid, point of care fluorescence immunoassay to be used with the Triage Meter or Triage MeterPlus for the quantitative measurement of B-Type Natriuretic Peptide (BNP) in EDTA anticoagulated whole blood or plasma specimens. The test is intended to be used as an aid in the:

* Diagnosis of heart failure

* Assessment of heart failure severity of

* Risk stratification of patients with acute coronary syndromes

* Risk stratification of patients with heart failure

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K051787: Triage BNP Test, Model 98000XR.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K051787

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026